- Home
- TVTX vs ARCB Comparison
TVTX vs ARCB Comparison
Compare TVTX & ARCB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TVTX
- ARCB
- Stock Information
- Founded
- TVTX 2008
- ARCB 1923
- Country
- TVTX United States
- ARCB United States
- Employees
- TVTX N/A
- ARCB N/A
- Industry
- TVTX Biotechnology: Pharmaceutical Preparations
- ARCB Trucking Freight/Courier Services
- Sector
- TVTX Health Care
- ARCB Industrials
- Exchange
- TVTX Nasdaq
- ARCB Nasdaq
- Market Cap
- TVTX 1.5B
- ARCB 1.7B
- IPO Year
- TVTX N/A
- ARCB N/A
- Fundamental
- Price
- TVTX $23.36
- ARCB $71.67
- Analyst Decision
- TVTX Strong Buy
- ARCB Buy
- Analyst Count
- TVTX 16
- ARCB 13
- Target Price
- TVTX $35.07
- ARCB $92.67
- AVG Volume (30 Days)
- TVTX 2.6M
- ARCB 259.9K
- Earning Date
- TVTX 10-30-2025
- ARCB 10-31-2025
- Dividend Yield
- TVTX N/A
- ARCB 0.65%
- EPS Growth
- TVTX N/A
- ARCB 27.88
- EPS
- TVTX N/A
- ARCB 6.77
- Revenue
- TVTX $333,865,000.00
- ARCB $4,054,102,000.00
- Revenue This Year
- TVTX $83.26
- ARCB N/A
- Revenue Next Year
- TVTX $43.19
- ARCB $5.58
- P/E Ratio
- TVTX N/A
- ARCB $10.86
- Revenue Growth
- TVTX 87.94
- ARCB N/A
- 52 Week Low
- TVTX $11.89
- ARCB $55.19
- 52 Week High
- TVTX $28.69
- ARCB $123.26
- Technical
- Relative Strength Index (RSI)
- TVTX 64.87
- ARCB 45.52
- Support Level
- TVTX $20.84
- ARCB $69.93
- Resistance Level
- TVTX $28.69
- ARCB $73.73
- Average True Range (ATR)
- TVTX 1.44
- ARCB 2.51
- MACD
- TVTX 0.62
- ARCB -0.08
- Stochastic Oscillator
- TVTX 56.60
- ARCB 20.83
About TVTX Travere Therapeutics Inc.
Travere Therapeutics Inc is a biopharmaceutical company. The company is focused on identifying, developing and delivering life-changing therapies to people living with rare kidney, liver, and metabolic diseases. Its pipeline candidate, sparsentan, is an investigational product candidate in late-stage development for focal segmental glomerulosclerosis (FSGS) and IgA nephropathy (IgAN)-rare kidney disorders that often cause end-stage kidney disease.
About ARCB ArcBest Corporation
ArcBest Corp is an integrated logistics company that leverages technology and a full suite of shipping and logistics solutions to meet customers' supply chain needs. The company has two reportable operating segments: Asset-Based, which generates maximum revenue, and Asset-Light. The Asset-Based segment's operations include national, inter-regional, and regional transportation of general commodities through standard, expedited, and guaranteed less-than-truckload services. The Asset-Light segment represents the company's offerings in ground expedite, intermodal, household goods moving, managed transportation, warehousing and distribution, and international freight transportation for air, ocean, and ground.